News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–53
Matches
53
Sources here
10
Companies here
1
Search results Stored financial headlines

Active search

53 matching headlines

Ticker or company: MBRXMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TradingKey Earnings Main company 🇺🇸 United States

MBRX|Moleculin Biotech Inc|Price:2.150|Chg%:+0.030

This article provides a comprehensive stock analysis of Moleculin Biotech Inc (MBRX) by TradingKey, highlighting its healthy fundamentals, high growth potential, and fair valuation. While institutional ownership is high and analysts rate it as a "Buy" with a significant upside, the stock has experienced …

MBRX main company
Sharemaestro market context Price below Trend Line 52 weeks -95.7% · Next-week setup negative 44.5% MBRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Moleculin Biotech Inc (MBRX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Moleculin Biotech Inc (MBRX) shareholder structure, listing major shareholders and their proportional holdings, as well as categorizing shareholders by type. It also presents institutional shareholding data over several quarters (from 2023Q4 to 2026Q1) including the number of …

MBRX main company
Sharemaestro market context Price below Trend Line 52 weeks -95.7% · Next-week setup negative 44.5% MBRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Ad-hoc-news.de Earnings Main company 🇺🇸 United States

MBRX stock trades around recent lows as Moleculin focuses on cash runway and clinical progress

Moleculin Biotech (MBRX) stock is trading around recent lows due to a constrained cash position and its early-stage oncology pipeline, with a market capitalization of approximately $30 million. The company reported a Q1 2024 net loss of $4.3 million (narrowed from Q1 2023) and …

MBRX main company
Sharemaestro market context Price below Trend Line 52 weeks -95.7% · Next-week setup negative 44.5% MBRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context